Diurnal Share Discussion Threads

[lovewinshatelosses] 07/4/2022 18:52

Well, now that 15p did not hold, anyone have any ideas of next resistance level, from a technical chart perspective? That stuff remains a complete mystery to me :)

[daveboy19] 07/4/2022 13:09

Hmm, my boot and Whitaker's bottom seems more apt.

[aimmafia] 07/4/2022 11:27

So therefore I make this a buy now - it has to bottom out somewhere

[daveboy19] 06/4/2022 09:53

Hey, Simon - stick a banana up Whitaker's exhaust for me when you're passing on the dog walk, cheers muchly :¬)

[wololol] 05/4/2022 07:58

For existing investors the share price has killed all sentiment. As a new investor I can't see why the WPhas droped so much. They have growing revenues , several assets at late stage development and a bug chunk of cash in the bank. The previous fund raises were not significantly discounted and they have stated next funding may not be dilutive. I don't expect them to raise money within a year and by that point the share price should be much higher. Therefore i am building a position pretty much at all time lows with so much news flow due this year.

[weatherman] 04/4/2022 14:00

Interesting that they are highlighting the new guy David Bevan - maybe he is being evaluated / lined up for the next CEO. "David Bevan, who was appointed Interim Head of Commercial in November 2021, has been promoted to the newly created role of Chief Business Officer. David has over 30 years of pharmaceutical expertise with a broad base of general management, sales, marketing and commercial experience, in large and medium-sized pharmaceutical companies with Global, EU and UK responsibility."

[wololol] 04/4/2022 12:46

15p is the bottom imo. Won't fall below that I wouldn't have thought. Lots of news due this year. I expect a climb to 30p in the next few weeks

[lovewinshatelosses] 04/4/2022 12:23

Watching with interest here. The less said about the departing directors the better I guess, but surely this company is worth more than the current market cap?
I agree with those who are calling out the appalling destruction of shareholder value here. Serious failure IMO, but the question on my mind is, what is a good re-entry point here?

[s34icknote] 04/4/2022 09:13

Still a seller out there Chunky late trade

[royalalbert] 04/4/2022 09:08

Well put Daveboy.

[daveboy19] 04/4/2022 08:47

And off it goes down again. What a disgusting performance with approved products on the shelf. Unreal.

[weatherman] 04/4/2022 08:04

DNL looks like a takeover target now - good assets at reduced price and no CEO.

[daveboy19] 04/4/2022 07:56

Leave it out! He’s awarded himself extra shares, then probably sold them all down from 80p then deserts so deserves no respect at all. This has peanut all to do with all the standard cliches blaming the loyal scapegoats. It’s just sheer greed. Rewarded for destruction of shareholder value. No excuses.

[74tom] 04/4/2022 07:45

He’s dedicated 14 years of his life to developing life changing treatments, so I’d say he deserves a bit more respect. Ultimately if you choose to invest in early stage pharma co’s then you have nobody but yourself to blame if you lose money. This has been high risk low reward for some time.

[glasswala] 04/4/2022 07:31

MW has been ousted !I think the whole BOD should have been sacked for this debacle. They have enriched themselves royally at the detriment of the shareholders .....they deserve to be left hung and dry too.

[weatherman] 01/4/2022 19:16

In reading the Calvine report again, it suggests that they could seek non-dilutive finance from both partnering on Efmody or Ditest, thus giving them more options. The company has valuable assets with two products to market. It looks like the fall has been well overdone imo.

[wololol] 01/4/2022 12:53

Looks set for a nice run to 30p. So oversold

[weatherman] 01/4/2022 10:16

The report suggests possible non-dilutive funding via an upfront fee for a partner for the testosterone treatment.

[bbonsall] 01/4/2022 09:53

hxxps://www.calvinepartners.com/diurnal-group-smc-decision
Latest update from Calvine.
Discounted cash flow valuation of 155p!!
Also good eps by 2025

[bradders51] 01/4/2022 09:45

A new Calvine report out.

hxxps://www.calvinepartners.com/diurnal-group-smc-decision

You may have to register.

[bjfanc] 31/3/2022 12:24

Yep, a business lesson, in how to completely smash confidence in your company.